http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006119647-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be16a3e79bb6b7348434c9b3f4e7c70b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a135a933620c99beab01d4ac785d25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa09ec019c4257070d8c32a7b2bfff46
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0676
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
filingDate 2006-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a3a82664acd3d1dadcda7bf2f4a2fb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_632424390dbbec2a6c1fa476a9726d10
publicationDate 2006-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006119647-A1
titleOfInvention Oligonucleotides and methods of use
abstract Oligonucleotide compositions that interact with mRNA encoding IAPP and result in reduced expression of the peptide precursor, pro-IAPP are useful in the treatment of type I and type II diabetes and for making transformed islet cells that can be used in the treatment of type I diabetes.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11746350-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022333114-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103882027-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103882027-A
priorityDate 2005-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6187991-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16954
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127912525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414051
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53682460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128347622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22051986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413788
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16186314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127517172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5126
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127516748
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128552287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127869814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129744730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245532038
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23666409

Total number of triples: 58.